Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial
Caron A. Jacobson, Julio C. Chávez, Alison R. Sehgal, Basem M. William, Javier Muñoz, Gilles Salles, Pashna N. Munshi, Carla Casulo, David G. Maloney, Sven de Vos, Ran Reshef, Lori A. Leslie, Ibrahim Yakoub‐Agha, Olalekan O. Oluwole, Henry C. Fung, Joseph D. Rosenblatt, John M. Rossi, Lovely Goyal, Vicki Plaks, Yin Yang, Remus Vezan, Mauro P. Avanzi, Sattva S. Neelapu
Topics & Concepts
MedicineFollicular lymphomaInternal medicineLymphomaFludarabineOncologyPopulationGastroenterologySurgeryCyclophosphamideChemotherapyEnvironmental healthCAR-T cell therapy researchLymphoma Diagnosis and TreatmentImmune Cell Function and Interaction